Farber Xintian
Signal active
Organization
Contact Information
Overview
Farber Xintian CRO company engaged in clinical services of radionuclide drugs. The company focuses on the field of nuclide drugs. Through cooperation with domestic experts in the field of nuclide drugs, the company introduces IP and relies on its own resource advantages to create a VIC model for domestic nuclide drugs.
About
Industries
Pharmaceutical, Medical, Therapeutics
Founded
2016
Employees
0
Headquarters locations
N/A
Social
N/A
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
2
Lead Investors
0
Total Funding Amount
$29.6M
Details
2
Farber Xintian has raised a total of $29.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 15.8M | ||
| 2024 | Early Stage Venture | 13.8M |
Investors
Farber Xintian is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| TaiYuAnKang | - | FUNDING ROUND - TaiYuAnKang | 15.8M |
| Farber Xintian | - | FUNDING ROUND - Farber Xintian | 13.8M |
| Yunhao Capital | - | FUNDING ROUND - Yunhao Capital | 13.8M |
| Farber Xintian | - | FUNDING ROUND - Farber Xintian | 13.8M |
Recent Activity
There is no recent news or activity for this profile.